You are here: Industry Insights > Brand Story > Dockweiler Asia Co., Ltd - Exhibitor Webinar

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Dockweiler Asia Co., Ltd - Exhibitor Webinar

August 10, 2020

Tag: Exhibitor Webinar , VEC , CPHI China

Favorites

Company Name: Dockweiler Asia Co., Ltd

Title：Pharmaceutical Tubing Systems and their Challenges

Speaker: Dr. Chatcharit Kiattisaksri

Position：Dr. Chatcharit Kiattisaksri graduated with a doctoral degree of material engineering from Kyoto University .

His expertise was in the area of material engineering, which involved the study of solidification process of metal alloys by using synchrotron radiation X-rays.

After that he moved back to Thailand to join Dockweiler Asia, a global supplier for ultra-high purity stainless steel tubes and fittings as an application manager.

For more information, click here to view my store.

Previous:T-Fit® Unique Insulation Tecnology- Exhibitor Webinar

Next:Fette Compacting (China) Co.,Ltd.- Exhibitor Webinar

What companies are developing CNS drugs in China?

ChatGTP/PharmaSourcesNovember 08, 2023

Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

PharmaSourcesMay 15, 2023

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

PharmaSources.comMay 27, 2022

Dockweiler Asia Co., Ltd - Exhibitor Webinar | Pharmasources.com

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

PharmaSources.comDecember 30, 2021

Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.

Dockweiler Asia Co., Ltd - Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may like
More>>

Dockweiler Asia Co., Ltd - Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may likeMore>>

You may like
More>>